Cubist Systematic Strategies’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-96,919
Closed -$1.32M 3938
2023
Q3
$1.68M Buy
+96,919
New +$2.02M 0.01% 1491
2023
Q2
Sell
-27,112
Closed -$589K 4069
2023
Q1
$638K Buy
27,112
+22,457
+482% +$603K ﹤0.01% 2508
2022
Q4
$130K Sell
4,655
-108,818
-96% -$2.78M ﹤0.01% 3740
2022
Q3
$2.65M Buy
113,473
+28,868
+34% +$872K 0.01% 1713
2022
Q2
$2.85M Buy
84,605
+71,478
+545% +$2.5M 0.02% 1520
2022
Q1
$459K Buy
+13,127
New +$449K ﹤0.01% 2589
2021
Q4
Sell
-124,383
Closed -$4.08M 3579
2021
Q3
$4.08M Buy
+124,383
New +$3.98M 0.05% 567

Other funds holding OGN

Cubist Systematic Strategies's OGN Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 96,919 shares — an estimated $1.32M sold.

Cubist Systematic Strategies first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $4.08M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 96,919 Organon & Co shares in Q4 2023, an estimated $1.32M.
  • Cubist Systematic Strategies first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Cubist Systematic Strategies's Organon & Co position peaked at $4.08M in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.